Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Abbott Diabetes Care

Approvalsdevice cleared25 Aug 2026

Abbott Diabetes Care

25 Aug 2026: Device cleared · Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System. Recorded in the openFDA device 510(k) data.

View the source record

Decided
25 Aug 2026
Device
Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System
Specialty
Clinical Chemistry
Country
United States
Location
Alameda, CA
Clearance type
Direct
510(k) number
DEN250049
Submitted
2025-09-29
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Abbott Diabetes Care

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Abbott Diabetes Care in our registers.

More in Clinical Chemistry

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.